Syringes and injectable drugs packaging sales will strengthen through 2036, anchored by syringes at 64.0% of the product type segment in 2026. The market was valued at USD 34.7 billion in 2025 and is expected to be worth USD 137.04 billion by 2036, creating an incremental opportunity of USD 97.72 billion.